准高内皮细胞位:癌症治疗的潜在策略
Weichang Yang1, Guofeng Zhu1, Shanshan Cai1
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, JiangxiMedical College, Nanchang University, Nanchang, China.
Annals of medicine
|December 3, 2025
概括
瘤中的高内皮静脉 (HEV) 有助于免疫监测,改善癌症预后. 针对这些血管,就像MECA-79一样,为癌症免疫治疗提供了一个有希望的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 高内皮静脉 (HEVs) 是专门的血管,对于淋巴细胞向淋巴结 (LNs) 转移至关重要.
- 在瘤微环境中,HEVs越来越多地被识别出来,形成三级淋巴体结构.
研究的目的:
- 审查 HEVs 在瘤和 LNs 的结构和功能变化.
- 研究HEVs在癌症预后和免疫治疗反应中的作用.
主要方法:
- 关于瘤和LNS中HEVs的研究的综合文献综述.
- 专注于HEV参与免疫反应和癌症进展.
- 考虑MECA-79作为一种特定的HEV标志物和治疗点.
主要成果:
- 与瘤相关的HEV与增强的免疫监测和更好的癌症预后有关.
- 存在HEV与增加的免疫细胞透相关,并影响免疫疗法的疗效.
- 针对HEV,包括通过MECA-79,显示出调节瘤免疫力的潜力.
结论:
- 在瘤中调节HEV是一种有前途的癌症治疗方法.
- 进一步的研究对于优化HEV准策略至关重要.
- 了解HEV在抗癌免疫力中的作用需要继续进行研究.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


